The PE Ratio as of September 2024 (TTM) for PMV Pharmaceuticals, Inc. (PMVP) is -1.56

According to PMV Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.56. This represents a change of -75.35% compared to the average of -6.33 of the last 4 quarters.

PMV Pharmaceuticals, Inc. (PMVP) Historical PE Ratio (quarterly & annually)

How has PMVP PE Ratio performed in the past?

The mean historical PE Ratio of PMV Pharmaceuticals, Inc. over the last ten years is -39.33. The current -1.56 PE Ratio has changed 296.63% with respect to the historical average. Over the past ten years (40 quarters), PMVP's PE Ratio was at its highest in in the March 2024 quarter at -1.50. The PE Ratio was at its lowest in in the June 2020 quarter at -50.61.

PMV Pharmaceuticals, Inc. (PMVP) PE Ratio by Quarter and Year

Discovering the peaks and valleys of PMV Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

PMV Pharmaceuticals, Inc. (PMVP) Average PE Ratio

How has PMVP PE Ratio performed in the past?

The current PE Ratio of PMV Pharmaceuticals, Inc. (PMVP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

PMV Pharmaceuticals, Inc. (PMVP) PE Ratio vs. Peers

How is PMVP’s PE Ratio compared to its peers?

PMV Pharmaceuticals, Inc.’s PE Ratio is greater than Eliem Therapeutics, Inc. (-3.49), greater than MediciNova, Inc. (-12.61), greater than Pharvaris N.V. (-8.20), greater than PepGen Inc. (-3.22), greater than Anebulo Pharmaceuticals, Inc. (-4.99), greater than Acrivon Therapeutics, Inc. Common Stock (-4.23), greater than Molecular Partners AG (-2.67), greater than Mineralys Therapeutics, Inc. (-4.63), greater than Edgewise Therapeutics, Inc. (-14.14), less than Rallybio Corporation (-0.66), less than Opthea Limited (-1.11), greater than Monte Rosa Therapeutics, Inc. (-3.11), less than Entrada Therapeutics, Inc. (4.84), greater than Vigil Neuroscience, Inc. (-1.65),

Build a custom stock screener for PMV Pharmaceuticals, Inc. (PMVP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PMV Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PMV Pharmaceuticals, Inc. (PMVP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PMV Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.